Restorative Neurotechnologies, a trailblazer in non-invasive neuromodulation therapies, has successfully raised $3,000,000 in its latest funding round, a testament to the growing recognition of its innovative approach to cognitive rehabilitation. The company is revolutionizing the landscape of cognitive therapy with its flagship product, MindLenses Professional, a CE-marked and Class IIa Medical Device designed for post-stroke cognitive rehabilitation. This cutting-edge therapy has outperformed traditional methods in multiple clinical studies, yielding superior outcomes in critical cognitive domains such as attention, memory, language, and executive functions—all within a significantly faster therapeutic cycle.
Founded by Professor Massimiliano Oliveri, whose groundbreaking research at the University of Palermo and Harvard has laid the foundation for this technology, Restorative Neurotechnologies is committed to enhancing the quality of life for those affected by cognitive impairments. This recent funding will empower the company to expand its clinical studies, further develop its product offerings, and enhance outreach efforts to medical professionals and patients alike. The company proudly boasts certification in its Quality Management System according to ISO 13485:2016, underscoring its dedication to safety and efficacy. As Restorative Neurotechnologies continues to push the boundaries of cognitive rehabilitation, this funding marks a pivotal step towards transforming outcomes for patients and reinforcing its position as a leader in the neurotechnology field.
